Page 71 - NobleCon21

Electromed, Inc.

SELECTED FINANCIAL ITEMS ELMD
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 16.26 15.68 17.39 16.89 66.22
Gross Profit 12.63 12.23 13.62 13.20 51.68
Gross Margin 78% 78% 78% 78% 78%
EBIT 2.54 2.14 3.25 2.67 10.60
EBIT Margin 16% 14% 19% 16% 16%
Net Income to Common Shareholders 1.97 1.89 2.20 2.14 8.20
Net Margin 12% 12% 13% 13% 12%

Balance Sheet Key Items
Total Assets 52.27 52.45 53.80 53.61 53.61
Cash & Short Term Investments 16.24 15.24 15.29 14.11 14.11
% of Assets 31% 29% 28% 26% 26%
Current Assets -Total 44.19 44.20 45.08 44.56 44.56
% of Assets 85% 84% 84% 83% 83%
Total Liabilities 8.67 8.51 10.59 8.87 8.87
% of Assets 17% 16% 20% 17% 17%
Current Liabilities - Total 8.67 8.51 10.47 8.76 8.76
% of Assets 17% 16% 19% 16% 16%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 43.60 43.94 43.21 44.75 44.75
% of Assets 83% 84% 80% 83% 83%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 3.15 2.07 3.86 0.17 9.25
Net Cash Flow - Investing (0.24) 0.15 (0.16) (0.27) (0.52)
Net Cash Flow - Financing (0.54) (3.22) (3.65) (1.08) (8.49)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference